Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Liver toxicity following reirradiation and multiple-target SBRT for primary hepatocellular carcinoma.
Authors
Jacob Hall
The University of North Carolina at Chapel Hill, Chapel Hill, NC
Jacob Hall , Andrew M Moon , Michael Young , Xianming Tan , Rami Darawsheh , Flora Danquah , Joel E. Tepper , Ted K. Yanagihara
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 514)
DOI
10.1200/JCO.2024.42.3_suppl.514
Abstract #
514
Poster Bd #
E1
Abstract Disclosures
Similar Posters
Poster
2015 Gastrointestinal Cancers Symposium
Evaluation of liver toxicity using Child-Pugh, MELD, and MELD-Na following stereotactic body radiation therapy (SBRT) of hepatocellular carcinomas.
First Author: Louis Lu
Poster
2020 Gastrointestinal Cancers Symposium
Clinical outcomes of hepatocellular carcinoma patients with Child-Pugh class B treated with stereotactic body radiation therapy.
First Author: J Richelcyn Baclay
Poster
2014 ASCO Annual Meeting
Final results of a phase II trial of stereotactic body radiotherapy (SBRT) in patients with hepatocellular carcinoma (HCC) with Child-Pugh class A (CPC-A).
First Author: Foster D Lasley
Poster
2023 ASCO Genitourinary Cancers Symposium
Stereotactic reirradiation for local prostate cancer recurrence: Mono-institutional experience of 108 patients.
First Author: Manon Baty